.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Deloitte
Colorcon
Cantor Fitzgerald
Healthtrust
QuintilesIMS
AstraZeneca
Chubb
Citi
McKinsey

Generated: November 23, 2017

DrugPatentWatch Database Preview

Estrogens, conjugated synthetic b - Generic Drug Details

« Back to Dashboard

What are the generic sources for estrogens, conjugated synthetic b and what is the scope of estrogens, conjugated synthetic b freedom to operate?

Estrogens, conjugated synthetic b
is the generic ingredient in one branded drug marketed by Teva Branded Pharm and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Estrogens, conjugated synthetic b has seventeen patent family members in nine countries.

There are three drug master file entries for estrogens, conjugated synthetic b. One supplier is listed for this compound.

Summary for estrogens, conjugated synthetic b

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm
ENJUVIA
estrogens, conjugated synthetic b
TABLET;ORAL021443-003May 10, 2004DISCNNoNo► Subscribe► SubscribeYY ► Subscribe
Teva Branded Pharm
ENJUVIA
estrogens, conjugated synthetic b
TABLET;ORAL021443-004May 10, 2004DISCNNoNo► Subscribe► SubscribeYY ► Subscribe
Teva Branded Pharm
ENJUVIA
estrogens, conjugated synthetic b
TABLET;ORAL021443-005Apr 27, 2007DISCNNoNo► Subscribe► SubscribeYY ► Subscribe
Teva Branded Pharm
ENJUVIA
estrogens, conjugated synthetic b
TABLET;ORAL021443-003May 10, 2004DISCNNoNo► Subscribe► SubscribeYY ► Subscribe
Teva Branded Pharm
ENJUVIA
estrogens, conjugated synthetic b
TABLET;ORAL021443-005Apr 27, 2007DISCNNoNo► Subscribe► SubscribeYY ► Subscribe
Teva Branded Pharm
ENJUVIA
estrogens, conjugated synthetic b
TABLET;ORAL021443-004May 10, 2004DISCNNoNo► Subscribe► SubscribeYY ► Subscribe
Teva Branded Pharm
ENJUVIA
estrogens, conjugated synthetic b
TABLET;ORAL021443-001Dec 20, 2004DISCNNoNo► Subscribe► SubscribeYY ► Subscribe
Teva Branded Pharm
ENJUVIA
estrogens, conjugated synthetic b
TABLET;ORAL021443-001Dec 20, 2004DISCNNoNo► Subscribe► SubscribeYY ► Subscribe
Teva Branded Pharm
ENJUVIA
estrogens, conjugated synthetic b
TABLET;ORAL021443-002Dec 20, 2004DISCNNoNo► Subscribe► SubscribeYY ► Subscribe
Teva Branded Pharm
ENJUVIA
estrogens, conjugated synthetic b
TABLET;ORAL021443-002Dec 20, 2004DISCNNoNo► Subscribe► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: estrogens, conjugated synthetic b

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,250,127 Heat-dissipating aluminum silicon carbide composite manufacturing method► Subscribe
7,459,445Estrogenic compounds and topical pharmaceutical formulations of the same► Subscribe
7,749,989Estrogenic compounds, methods of using and methods of administering the same► Subscribe
8,227,454Estrogenic compounds, pharmaceutical compositions and formulations comprising the same► Subscribe
7,989,436Estrogenic compounds and pharmaceutical formulations comprising the same► Subscribe
7,179,799(3) and (6) substituted estrogenic compounds► Subscribe
6,844,334 (3) and (6) substitued estrogenic compounds► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: estrogens, conjugated synthetic b

Country Document Number Estimated Expiration
Australia4541701► Subscribe
South Korea20030064614► Subscribe
South Korea20070045364► Subscribe
South Korea100804224► Subscribe
European Patent Office1267852► Subscribe
World Intellectual Property Organization (WIPO)0168669► Subscribe
Japan2011256181► Subscribe
Australia4733701► Subscribe
MexicoPA02008856► Subscribe
World Intellectual Property Organization (WIPO)0168074► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
UBS
Cantor Fitzgerald
Farmers Insurance
Express Scripts
Daiichi Sankyo
Moodys
Colorcon
Dow
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot